Provider Training for Long-Acting Injectable Cabotegravir (CAB-LA) as HIV Pre-Exposure Prophylaxis (PrEP) By Jhpiego, an affiliate of Johns Hopkins University

About this activity

Lesson 1: The Basics of Cabotegravir (CAB) for HIV Prevention Lesson 2: Relative Advantages and Disadvantages of Long-acting Cabotegravir Lesson 3: Assessing for CAB-LA Clinical Contraindications/Eligibility Lesson 4: CAB-LA Injection Video Lesson 5: Assessing and Managing Side Effects and Adverse Reactions of CAB-LA Lesson 6: Follow-Up Schedule and Visit Components Lesson 7: Managing Missed Visits Lesson 8: Using Oral PrEP as a Bridge to Postpone Reinjection Appointments Lesson 9: Discontinuation of CAB-LA and Tail Phase Monitoring Lesson 10: Method Choice: Framing Method Benefits Relative to Client Priorities Lesson 11: Cross-Cutting Counseling Techniques Lesson 12: Translating Technical Information into Counseling Messages 3Lesson 13: CAB-LA in Pregnant and/or Breastfeeding Clients